Disturbed mitochondrial dynamics and neurodegenerative disorders (original) (raw)

• Chan, D. C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 125, 1241–1252 (2006).
  Article CAS PubMed Google Scholar
• Yu-Wai-Man, P., Griffiths, P. G., Hudson, G. & Chinnery, P. F. Inherited mitochondrial optic neuropathies. J. Med. Genet. 46, 145–158 (2009).
  Article CAS PubMed Google Scholar
• Reilly, M. M., Shy, M. E., Muntoni, F. & Pareyson, D. 168th ENMC International Workshop: outcome measures and clinical trials in Charcot–Marie–Tooth disease (CMT). Neuromuscul. Disord. 20, 839–846 (2010).
  Article CAS PubMed Google Scholar
• Saporta, A. S. D. et al. Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22–33 (2011).
  Article PubMed PubMed Central Google Scholar
• Yu-Wai-Man, P., Lenaers, G. & Chinnery, P. F. in Mitochondrial Disorders Caused by Nuclear Genes (ed. Wong, L.-J.C.) 141–161 (Springer, 2013).
  Book Google Scholar
• Belenguer, P. & Pellegrini, L. The dynamin GTPase OPA1: more than mitochondria? Biochim. Biophys. Acta 1833, 176–183 (2013).
  Article CAS PubMed Google Scholar
• Chen, H. C. et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160, 189–200 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Eura, Y., Ishihara, N., Yokota, S. & Mihara, K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J. Biochem. 134, 333–344 (2003).
  Article CAS PubMed Google Scholar
• Lenaers, G. et al. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int. J. Biochem. Cell Biol. 41, 1866–1874 (2009).
  Article CAS PubMed Google Scholar
• Frezza, C. et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177–189 (2006).
  Article CAS PubMed Google Scholar
• Amati-Bonneau, P. et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann. Neurol. 58, 958–963 (2005).
  Article CAS PubMed Google Scholar
• Zanna, C. et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131, 352–367 (2008).
  Article PubMed Google Scholar
• Loson, O. C., Song, Z., Chen, H. & Chan, D. C. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol. Biol. Cell 24, 659–667 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Otera, H. et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191, 1141–1158 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rostovtseva, T. K. et al. Bax activates endophilin B1 oligomerization and lipid membrane vesiculation. J. Biol. Chem. 284, 34390–34399 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tondera, D. et al. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J. Cell Sci. 118, 3049–3059 (2005).
  Article CAS PubMed Google Scholar
• Takahashi, Y., Meyerkord, C. L. & Wang, H. G. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy. Cell Death Differ. 16, 947–955 (2009).
  Article CAS PubMed Google Scholar
• Olichon, A. et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 523, 171–176 (2002).
  Article CAS PubMed Google Scholar
• Olichon, A. et al. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ. 14, 682–692 (2007).
  Article CAS PubMed Google Scholar
• Duvezin-Caubet, S. et al. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol. Biol. Cell 18, 3582–3590 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Martinelli, P. & Rugarli, E. I. Emerging roles of mitochondrial proteases in neurodegeneration. Biochim. Biophys. Acta 1797, 1–10 (2010).
  Article CAS PubMed Google Scholar
• Ishihara, N., Fujita, Y., Oka, T. & Mihara, K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25, 2966–2977 (2006).
  CAS PubMed PubMed Central Google Scholar
• Griparic, L., Kanazawa, T. & van der Bliek, A. M. Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J. Cell Biol. 178, 757–764 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Song, Z., Chen, H., Fiket, M., Alexander, C. & Chan, D. C. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J. Cell Biol. 178, 749–755 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• McQuibban, G. A., Saurya, S. & Freeman, M. Mitochondrial membrane remodelling regulated by a conserved rhomboid protease. Nature 423, 537–541 (2003).
  Article CAS PubMed Google Scholar
• Cipolat, S. et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126, 163–175 (2006).
  Article CAS PubMed Google Scholar
• Ehses, S. et al. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J. Cell Biol. 187, 1023–1036 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Head, B., Griparic, L., Amiri, M., Gandre-Babbe, S. & van der Bliek, A. M. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J. Cell Biol. 187, 959–966 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Mishra, P., Carelli, V., Manfredi, G. & Chan, D. C. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 19, 630–641 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Pich, S. et al. The Charcot–Marie–Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14, 1405–1415 (2005).
  Article CAS PubMed Google Scholar
• Agier, V. et al. Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations. Biochim. Biophys. Acta 1822, 1570–1580 (2012).
  Article CAS PubMed Google Scholar
• Chevrollier, A. et al. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann. Neurol. 63, 794–798 (2008).
  Article PubMed Google Scholar
• Cogliati, S. et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155, 160–171 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lodi, R. et al. Deficit of in vivo mitochondrial ATP production in _OPA1_-related dominant optic atrophy. Ann. Neurol. 56, 719–723 (2004).
  Article CAS PubMed Google Scholar
• Lodi, R. et al. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations. Arch. Neurol. 68, 67–73 (2011).
  Article PubMed Google Scholar
• Yu-Wai-Man, P., Trenell, M. I., Hollingsworth, K. G., Griffiths, P. G. & Chinnery, P. F. OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy. Brain 134, e164 (2011).
  Article PubMed Google Scholar
• Del Bo, R. et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 71, 1959–1966 (2008).
  Article CAS PubMed Google Scholar
• Area-Gomez, E. et al. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31, 4106–4123 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• de Brito, O. M. & Scorrano, L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J. 29, 2715–2723 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Kornmann, B. et al. An ER–mitochondria tethering complex revealed by a synthetic biology screen. Science 325, 477–481 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Merkwirth, C. & Langer, T. Mitofusin 2 builds a bridge between ER and mitochondria. Cell 135, 1165–1167 (2008).
  Article CAS PubMed Google Scholar
• Lam, A. K. M. & Galione, A. The endoplasmic reticulum and junctional membrane communication during calcium signaling. Biochim. Biophys. Acta 1833, 2542–2559 (2013).
  Article CAS PubMed Google Scholar
• Patron, M. et al. MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity. Mol. Cell 53, 726–737 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Baughman, J. M. et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341–345 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Perocchi, F. et al. MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake. Nature 467, 291–296 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Csordas, G. et al. MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca2+ uniporter. Cell Metab. 17, 976–987 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Logan, C. V. et al. Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat. Genet. 46, 188–193 (2014).
  Article CAS PubMed Google Scholar
• Dayanithi, G. et al. Characterization of Ca2+ signalling in postnatal mouse retinal ganglion cells: involvement of OPA1 in Ca2+ clearance. Ophthalmic Genet. 31, 53–65 (2010).
  Article CAS PubMed Google Scholar
• Kushnareva, Y. E. et al. Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death Differ. 20, 353–365 (2013).
  Article CAS PubMed Google Scholar
• Singaravelu, K. et al. Mitofusin 2 regulates STIM1 migration from the Ca2+ store to the plasma membrane in cells with depolarized mitochondria. J. Biol. Chem. 286, 12189–12201 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• de Brito, O. M. & Scorrano, L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456, 605–611 (2008).
  Article PubMed CAS Google Scholar
• Friedman, J. R. et al. ER tubules mark sites of mitochondrial division. Science 334, 358–362 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hayashi, T., Rizzuto, R., Hajnoczky, G. & Su, T.-P. MAM: more than just a housekeeper. Trends Cell Biol. 19, 81–88 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Schon, E. A. & Przedborski, S. Mitochondria: the next (neurode) generation. Neuron 70, 1033–1053 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Arnoult, D. Mitochondrial fragmentation in apoptosis. Trends Cell Biol. 17, 6–12 (2007).
  Article CAS PubMed Google Scholar
• Suen, D. F., Norris, K. L. & Youle, R. J. Mitochondrial dynamics and apoptosis. Genes Dev. 22, 1577–1590 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Levine, B., Sinha, S. & Kroemer, G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4, 600–606 (2008).
  Article CAS PubMed Google Scholar
• Renault, T. T. & Manon, S. Bax: addressed to kill. Biochimie 93, 1379–1391 (2011).
  Article CAS PubMed Google Scholar
• Walensky, L. D. & Gavathiotis, E. BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. Trends Biochem. Sci. 36, 642–652 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ekert, P. G. & Vaux, D. L. The mitochondrial death squad: hardened killers or innocent bystanders? Curr. Opin. Cell Biol. 17, 626–630 (2005).
  Article CAS PubMed Google Scholar
• Scorrano, L. et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2, 55–67 (2002).
  Article CAS PubMed Google Scholar
• Olichon, A. et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 278, 7743–7746 (2003).
  Article CAS PubMed Google Scholar
• Arnoult, D., Grodet, A., Lee, Y. J., Estaquier, J. & Blackstone, C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J. Biol. Chem. 280, 35742–35750 (2005).
  Article CAS PubMed Google Scholar
• Karbowski, M., Norris, K. L., Cleland, M. M., Jeong, S.-Y. & Youle, R. J. Role of Bax and Bak in mitochondrial morphogenesis. Nature 443, 658–662 (2006).
  Article CAS PubMed Google Scholar
• Neuspiel, M., Zunino, R., Gangaraju, S., Rippstein, P. & McBride, H. Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J. Biol. Chem. 280, 25060–25070 (2005).
  Article CAS PubMed Google Scholar
• Chinnery, P. F., Samuels, D. C., Elson, J. & Turnbull, D. M. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet 360, 1323–1325 (2002).
  Article CAS PubMed Google Scholar
• Rugarli, E. I. & Langer, T. Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 31, 1336–1349 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Twig, G. & Shirihai, O. S. The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal. 14, 1939–1951 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Twig, G., Hyde, B. & Shirihai, O. S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 1777, 1092–1097 (2008).
  Article CAS PubMed Google Scholar
• Twig, G. et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27, 433–446 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Youle, R. J. & van der Bliek, A. M. Mitochondrial fission, fusion, and stress. Science 337, 1062–1065 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gegg, M. E. et al. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet. 19, 4861–4870 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuda, N. et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211–221 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Narendra, D., Tanaka, A., Suen, D.-F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795–803 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Pallanck, L. Mitophagy: mitofusin recruits a mitochondrial killer. Curr. Biol. 23, R570–R572 (2013).
  Article CAS PubMed Google Scholar
• Chen, Y. & Dorn, G. W. 2nd. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340, 471–475 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Kane, L. A. & Youle, R. J. PINK1 and Parkin flag Miro to direct mitochondrial traffic. Cell 147, 721–723 (2011).
  Article CAS PubMed Google Scholar
• Shin, J. H. et al. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell 144, 689–702 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mueller-Rischart, A. K. et al. The E3 ligase Parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol. Cell 49, 908–921 (2013).
  Article CAS Google Scholar
• Liu, S. et al. Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet. 8, e1002537 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893–906 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sterky, F. H., Lee, S., Wibom, R., Olson, L. & Larsson, N.G. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl Acad. Sci. USA 108, 12937–12942 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yu-Wai-Man, P. et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology 117, 1538–1546 (2010).
  Article PubMed Google Scholar
• Yu-Wai-Man, P. & Chinnery, P. F. Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates. Ophthalmology 120, 1712–1712.e1 (2013).
  Article PubMed Google Scholar
• Yu-Wai-Man, P., Bailie, M., Atawan, A., Chinnery, P. F. & Griffiths, P. G. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Eye 25, 597–601 (2011).
  Article CAS Google Scholar
• Cohn, A. C. et al. The natural history of _OPA1_-related autosomal dominant optic atrophy. Br. J. Ophthalmol. 92, 1333–1336 (2008).
  Article CAS PubMed Google Scholar
• Yu-Wai-Man, P. et al. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. Ophthalmology 118, 558–563 (2011).
  Article PubMed Google Scholar
• Votruba, M., Moore, A. T. & Bhattacharya, S. S. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J. Med. Genet. 35, 793–800 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Bailie, M., Votruba, M., Griffiths, P. G., Chinnery, P. F. & Yu-Wai-Man, P. Visual and psychological morbidity among patients with autosomal dominant optic atrophy. Acta Ophthalmol. 91, e413–e414 (2013).
  Article PubMed PubMed Central Google Scholar
• Alexander, C. et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26, 211–215 (2000).
  Article CAS PubMed Google Scholar
• Delettre, C. et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207–210 (2000).
  Article CAS PubMed Google Scholar
• Ferre, M. et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum. Mutat. 30, E692–E705 (2009).
  Article PubMed Google Scholar
• Aijaz, S., Erskine, L., Jeffery, G., Bhattacharya, S. S. & Votruba, M. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. Invest. Ophthalmol. Vis. Sci. 45, 1667–1673 (2004).
  Article PubMed Google Scholar
• Bette, S., Schlaszus, H., Wissinger, B., Meyermann, R. & Mittelbronn, M. OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain. Acta Neuropathol. 109, 393–399 (2005).
  Article CAS PubMed Google Scholar
• Pesch, U. E. et al. OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina. Invest. Ophthalmol. Vis. Sci. 45, 4217–4225 (2004).
  Article PubMed Google Scholar
• Wang, A. G., Fann, M. J., Yu, H. Y. & Yen, M. Y. OPA1 expression in the human retina and optic nerve. Exp. Eye Res. 83, 1171–1178 (2006).
  Article CAS PubMed Google Scholar
• Marchbank, N. J. et al. Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease. J. Med. Genet. 39, e47 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Amati-Bonneau, P. et al. The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene. Am. J. Ophthalmol. 136, 1170–1171 (2003).
  Article CAS PubMed Google Scholar
• Leruez, S. et al. Sensorineural hearing loss in OPA1-linked disorders. Brain 136, e236 (2013).
  Article PubMed Google Scholar
• Amati-Bonneau, P. et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes. Brain 131, 338–351 (2008).
  Article PubMed Google Scholar
• Hudson, G. et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131, 329–337 (2008).
  Article PubMed Google Scholar
• Spinazzi, M. et al. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Hum. Mol. Genet. 17, 3291–3302 (2008).
  Article CAS PubMed Google Scholar
• Yu-Wai-Man, P. et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133, 771–786 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Pretegiani, E. et al. Spastic paraplegia in 'dominant optic atrophy plus' phenotype due to OPA1 mutation. Brain 134, e195 (2011).
  Article PubMed Google Scholar
• Marelli, C. et al. Heterozygous OPA1 mutations in Behr syndrome. Brain 134, e169 (2011).
  Article PubMed Google Scholar
• Liskova, P. et al. Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol. 91, E225–E231 (2013).
  Article CAS PubMed Google Scholar
• Ranieri, M. et al. Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families. J. Neurol. Sci. 315, 146–149 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zuchner, S. et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot–Marie–Tooth neuropathy type 2A. Nat. Genet. 36, 449–451 (2004).
  Article PubMed CAS Google Scholar
• Feely, S. M. et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 76, 1690–1696 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Verhoeven, K. et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot–Marie–Tooth type 2. Brain 129, 2093–2102 (2006).
  Article PubMed Google Scholar
• Zuchner, S. et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann. Neurol. 59, 276–281 (2006).
  Article CAS PubMed Google Scholar
• Polke, J. M. et al. Recessive axonal Charcot–Marie–Tooth disease due to compound heterozygous mitofusin 2 mutations. Neurology 77, 168–173 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, H., McCaffery, J. M. & Chan, D. C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130, 548–562 (2007).
  Article CAS PubMed Google Scholar
• Chen, H. et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141, 280–289 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Larsson, N. G. et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 18, 231–236 (1998).
  Article CAS PubMed Google Scholar
• Garrido, N. et al. Composition and dynamics of human mitochondrial nucleoids. Mol. Biol. Cell 14, 1583–1596 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Holt, I. J. et al. Mammalian mitochondrial nucleoids: organizing an independently minded genome. Mitochondrion 7, 311–321 (2007).
  Article CAS PubMed Google Scholar
• Kaufman, B. A. et al. The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol. Biol. Cell 18, 3225–3236 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hudson, G. & Chinnery, P. F. Mitochondrial DNA polymerase-γ and human disease. Hum. Mol. Genet. 15, R244–R252 (2006).
  Article CAS PubMed Google Scholar
• McFarland, R., Taylor, R. W. & Turnbull, D. M. A neurological perspective on mitochondrial disease. Lancet Neurol. 9, 829–840 (2010).
  Article CAS PubMed Google Scholar
• Schapira, A. H. Mitochondrial diseases. Lancet 379, 1825–1834 (2012).
  Article CAS PubMed Google Scholar
• Alberio, S., Mineri, R., Tiranti, V. & Zeviani, M. Depletion of mtDNA: syndromes and genes. Mitochondrion 7, 6–12 (2007).
  Article CAS PubMed Google Scholar
• Chinnery, P. F. & Zeviani, M. 155th ENMC workshop: polymerase gamma and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands. Neuromuscul. Disord. 18, 259–267 (2008).
  Article PubMed Google Scholar
• Suomalainen, A. & Isohanni, P. Mitochondrial DNA depletion syndromes—many genes, common mechanisms. Neuromuscul. Disord. 20, 429–437 (2010).
  Article PubMed Google Scholar
• Del Bo, R. et al. Remarkable infidelity of polymerase γA associated with mutations in POLG1 exonuclease domain. Neurology 61, 903–908 (2003).
  Article CAS PubMed Google Scholar
• Nishigaki, Y., Marti, R., Copeland, W. C. & Hirano, M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J. Clin. Invest. 111, 1913–1921 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Wanrooij, S. et al. Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA. Nucleic Acids Res. 32, 3053–3064 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Yu-Wai-Man, P. et al. OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules. Hum. Mol. Genet. 19, 3043–3052 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Durham, S. E., Samuels, D. C., Cree, L. M. & Chinnery, P. F. Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A→G. Am. J. Hum. Genet. 81, 189–195 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Koopman, W. J., Distelmaier, F., Smeitink, J. A. & Willems, P. H. OXPHOS mutations and neurodegeneration. EMBO J. 32, 9–29 (2013).
  Article CAS PubMed Google Scholar
• Taylor, R. W., Schaefer, A. M., Barron, M. J., McFarland, R. & Turnbull, D. M. The diagnosis of mitochondrial muscle disease. Neuromuscul. Disord. 14, 237–245 (2004).
  Article PubMed Google Scholar
• Rouzier, C. et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype. Brain 135, 23–34 (2012).
  Article PubMed Google Scholar
• Zeviani, M. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 131, 314–317 (2008).
  Article PubMed Google Scholar
• Vidoni, S., Zanna, C., Rugolo, M., Sarzi, E. & Lenaers, G. Why mitochondria must fuse to maintain their genome integrity. Antioxid. Redox Signal. 19, 379–388 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Stewart, J. D. et al. OPA1 in multiple mitochondrial DNA deletion disorders. Neurology 71, 1829–1831 (2008).
  Article CAS PubMed Google Scholar
• Elachouri, G. et al. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res. 21, 12–20 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Payne, B. A. et al. Universal heteroplasmy of human mitochondrial DNA. Hum. Mol. Genet. 22, 384–390 (2013).
  Article CAS PubMed Google Scholar
• Sitarz, K. S. et al. OPA1 mutations induce mtDNA proliferation in leukocytes of patients with dominant optica atrophy. Neurology 79, 1515–1517 (2012).
  Article PubMed PubMed Central Google Scholar
• Iommarini, L. et al. Revisiting the issue of mitochondrial DNA content in optic mitochondriopathies. Neurology 79, 1517–1519 (2012).
  Article PubMed Google Scholar
• Sitarz, K. S. et al. MFN2 mutations cause compensatory mitochondrial DNA proliferation. Brain 135, e219 (2012).
  Article PubMed PubMed Central Google Scholar
• Renaldo, F. et al. MFN2, a new gene responsible for mitochondrial DNA depletion. Brain 135, e223 (2012).
  Article PubMed Google Scholar
• Yu-Wai-Man, P. & Chinnery, P. F. Dysfunctional mitochondrial maintenance: what breaks the circle of life? Brain 135, 9–11 (2012).
  Article PubMed Google Scholar
• Salinas, S., Proukakis, C., Crosby, A. & Warner, T. T. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 7, 1127–1138 (2008).
  Article CAS PubMed Google Scholar
• Blackstone, C., O'Kane, C. J. & Reid, E. Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat. Rev. Neurosci. 12, 31–42 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Timmerman, V., Clowes, V. E. & Reid, E. Overlapping molecular pathological themes link Charcot–Marie–Tooth neuropathies and hereditary spastic paraplegias. Exp. Neurol. 246, 14–25 (2013).
  Article CAS PubMed Google Scholar
• Harding, A. E. Classification of the hereditary ataxias and paraplegias. Lancet 1, 1151–1155 (1983).
  Article CAS PubMed Google Scholar
• Casari, G. et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973–983 (1998).
  Article CAS PubMed Google Scholar
• Ferreirinha, F. et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 113, 231–242 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Klebe, S. et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain 135, 2980–2993 (2012).
  Article PubMed PubMed Central Google Scholar
• van Gassen, K. L. et al. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. Brain 135, 2994–3004 (2012).
  Article PubMed Google Scholar
• Greaves, L. C. et al. Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO. Invest. Opthalmol. Vis. Sci. 51, 3340–3346 (2010).
  Article Google Scholar
• Pfeffer, G. et al. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain 137, 1323–1336 (2014).
  Article PubMed PubMed Central Google Scholar
• Wedding, I. M. et al. Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions. PLoS ONE 9, e86340 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Di Bella, D. et al. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat. Genet. 42, 313–320 (2010).
  Article CAS PubMed Google Scholar
• Pierson, T. M. et al. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet. 7, e1002325 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Maltecca, F. et al. Respiratory dysfunction by AFG3L2 deficiency causes decreased mitochondrial calcium uptake via organellar network fragmentation. Hum. Mol. Genet. 21, 3858–3870 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Almajan, E. R. et al. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival. J. Clin. Invest. 122, 4048–4058 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kondadi, A. K. et al. Loss of the m-AAA protease subunit AFG3L2 causes mitochondrial transport defects and tau hyperphosphorylation. EMBO J. 33, 1011–1026 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, T. T. et al. Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease. Proc. Natl Acad. Sci. USA 111, E3631–E3640 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Paisan-Ruiz, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595–600 (2004).
  Article CAS PubMed Google Scholar
• Macdonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's-disease chromosomes. Cell 72, 971–983 (1993).
  Article Google Scholar
• Engert, J. C. et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat. Genet. 24, 120–125 (2000).
  Article CAS PubMed Google Scholar
• Costa, V. et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol. Med. 2, 490–503 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Song, W. et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 17, 377–382 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Girard, M. et al. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS). Proc. Natl Acad. Sci. USA 109, 1661–1666 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 21, 1931–1944 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Shirendeb, U. et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 20, 1438–1455 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shirendeb, U. P. et al. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Hum. Mol. Genet. 21, 406–420 (2012).
  Article CAS PubMed Google Scholar
• Manczak, M., Calkins, M. J. & Reddy, P. H. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet. 20, 2495–2509 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Manczak, M. & Reddy, P. H. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 21, 2538–2547 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U. & Reddy, P. H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 20, 4515–4529 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Schon, E. A. & Area-Gomez, E. Mitochondria-associated ER membranes in Alzheimer disease. Mol. Cell. Neurosci. 55, 26–36 (2013).
  Article CAS PubMed Google Scholar
• Hedskog, L. et al. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl Acad. Sci. USA 110, 7916–7921 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bannwarth, S. et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137, 2329–2345 (2014).
  Article PubMed PubMed Central Google Scholar
• Chaussenot, A. et al. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol. Aging 35, 2884.e1–2884.e4 (2014).
  Article CAS Google Scholar
• Yu-Wai-Man, P., Votruba, M., Moore, A. T. & Chinnery, P. F. Treatment strategies for inherited optic neuropathies: past, present and future. Eye (Lond.) 28, 527–537 (2014).
  Article CAS Google Scholar
• Yu-Wai-Man, P., Griffiths, P. G. & Chinnery, P. F. Mitochondrial optic neuropathies—disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 30, 81–114 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Carelli, V., La Morgia, C. & Sadun, A. A. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options. Curr. Opin. Neurol. 26, 52–58 (2013).
  Article CAS PubMed Google Scholar
• Chen, H. & Chan, D. C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 18, R169–R176 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3, 331–338 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bove, J., Martinez-Vicente, M. & Vila, M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nat. Rev. Neurosci. 12, 437–452 (2011).
  Article CAS PubMed Google Scholar
• Harris, H. & Rubinsztein, D. C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108–117 (2012).
  Article CAS Google Scholar
• Man, P. Y., Turnbull, D. M. & Chinnery, P. F. Leber hereditary optic neuropathy. J. Med. Genet. 39, 162–169 (2002).
  Article PubMed Central Google Scholar
• Klopstock, T. et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 134, 2677–2686 (2011).
  Article PubMed PubMed Central Google Scholar
• Carelli, V. et al. Idebenone treatment In Leber's hereditary optic neuropathy. Brain 134, e188 (2011).
  Article PubMed Google Scholar
• Klopstock, T. et al. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy. Brain 136, e230 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sadun, A. A. et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch. Neurol. 69, 331–338 (2012).
  Article PubMed Google Scholar
• Cipolat, S., de Brito, O. M., Dal Zilio, B. & Scorrano, L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl Acad. Sci. USA 101, 15927–15932 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• MacAskill, A. F. et al. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 61, 541–555 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Misko, A., Jiang, S., Wegorzewska, I., Milbrandt, J. & Baloh, R. H. Mitofusin 2 Is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci. 30, 4232–4240 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cassidy-Stone, A. et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell 14, 193–204 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Cereghetti, G. M., Costa, V. & Scorrano, L. Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin. Cell Death Differ. 17, 1785–1794 (2010).
  Article CAS PubMed Google Scholar
• Iwasawa, R., Mahul-Mellier, A.-L., Datler, C., Pazarentzos, E. & Grimm, S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 30, 556–568 (2011).
  Article CAS PubMed Google Scholar
• Wells, T. et al. Opa3, a novel regulator of mitochondrial function, controls thermogenesis and abdominal fat mass in a mouse model for Costeff syndrome. Hum. Mol. Genet. 21, 4836–4844 (2012).
  Article CAS PubMed Google Scholar
• Huizing, M. et al. OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. Mol. Genet. Metab. 100, 149–154 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ryu, S.-W., Jeong, H. J., Choi, M., Karbowski, M. & Choi, C. Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation. Cell. Mol. Life Sci. 67, 2839–2850 (2010).
  Article CAS PubMed Google Scholar
• Niemann, A., Ruegg, M., La Padula, V., Schenone, A. & Suter, U. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot–Marie–Tooth disease. J. Cell Biol. 170, 1067–1078 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Niemann, A., Wagner, K. M., Ruegg, M. & Suter, U. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol. Dis. 36, 509–520 (2009).
  Article CAS PubMed Google Scholar
• Claramunt, R. et al. Genetics of Charcot–Marie–Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J. Med. Genet. 42, 358–365 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Waterham, H. R. et al. A lethal defect of mitochondrial and peroxisomal fission. N. Engl. J.Med. 356, 1736–1741 (2007).
  Article CAS PubMed Google Scholar
• Chang, C.-R. et al. A lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division. J. Biol. Chem. 285, 32494–32503 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Reynier, P. et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J. Med. Genet. 41, e110 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Baxter, R. V. et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 30, 21–22 (2002).
  Article CAS PubMed Google Scholar
• Anikster, Y., Kleta, R., Shaag, A., Gahl, W. A. & Elpeleg, O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am. J. Hum. Genet. 69, 1218–1224 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yarosh, W. et al. The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet. 4, e6 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Tang, S., Le, P. K., Tse, S., Wallace, D. C. & Huang, T. Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production. PLoS ONE 4, e4492 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Shahrestani, P. et al. Heterozygous mutation of Drosophila Opa1 causes the development of multiple organ abnormalities in an age-dependent and organ-specific manner. PLoS ONE 4, e6867 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Rahn, J. J., Stackley, K. D. & Chan, S. S. Opa1 is required for proper mitochondrial metabolism in early development. PLoS ONE 8, e59218 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Davies, V. J. et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 16, 1307–1318 (2007).
  Article CAS PubMed Google Scholar
• Alavi, M. V. et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 130, 1029–1042 (2007).
  Article PubMed Google Scholar
• Alavi, M. V. et al. Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy. Exp. Neurol. 220, 404–409 (2009).
  Article CAS PubMed Google Scholar
• Moore, B. A., Aviles, G. D., Larkins, C. E., Hillman, M. J. & Caspary, T. Mitochondrial retention of Opa1 is required for mouse embryogenesis. Mamm. Gen. 21, 350–360 (2010).
  Article CAS Google Scholar
• Sarzi, E. et al. The human OPA1 delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. Brain 135, 3599–3613 (2012).
  Article PubMed Google Scholar
• Williams, P. A., Morgan, J. E. & Votruba, M. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 133, 2942–2951 (2010).
  Article PubMed Google Scholar
• Williams, P. A. et al. Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 135, 493–505 (2012).
  Article PubMed Google Scholar
• Yu-Wai-Man, P. et al. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atropy. Invest. Opthalmol. Vis. Sci. 50, 4561–4566 (2009).
  Article Google Scholar
• Chen, Y. et al. Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca2+ crosstalk. Circ. Res. 111, 863–875 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dorn, G. W. 2nd et al. MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ. Res. 108, 12–17 (2011).
  Article CAS PubMed Google Scholar
• Eschenbacher, W. H. et al. Two rare human mitofusin 2 mutations alter mitochondrial dynamics and induce retinal and cardiac pathology in Drosophila. PLoS ONE 7, e44296 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Deng, H., Dodson, M. W., Huang, H. & Guo, M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl Acad. Sci. USA 105, 14503–14508 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chapman, A. L., Bennett, E. J., Ramesh, T. M., De Vos, K. J. & Grierson, A. J. Axonal transport defects in a mitofusin 2 loss of function model of Charcot–Marie–Tooth disease in zebrafish. PLoS ONE 8, e67276 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Vettori, A. et al. Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot–Marie–Tooth type 2A neuropathy. Neuromuscul. Disord. 21, 58–67 (2011).
  Article PubMed Google Scholar
• Chen, L. et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J. Am. Heart Assoc. 1, e003012 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Lee, S. et al. Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum. Mol. Genet. 21, 4827–4835 (2012).
  Article CAS PubMed Google Scholar
• Pham, A. H., Meng, S., Chu, Q. N. & Chan, D. C. Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum. Mol. Genet. 21, 4817–4826 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Detmer, S. A., Velde, C. V., Cleveland, D. W. & Chan, D. C. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot–Marie–Tooth type 2A. Hum. Mol. Genet. 17, 367–375 (2008).
  Article CAS PubMed Google Scholar
• Cartoni, R. et al. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot–Marie–Tooth neuropathy type 2A. Brain 133, 1460–1469 (2010).
  Article PubMed Google Scholar
• Guillet, V. et al. Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation. FASEB J. 25, 1618–1627 (2011).
  Article CAS PubMed Google Scholar